Tue. 12 Mar 2024, 8:11am ET
Benzinga
Earnings, News
Black Diamond Therapeutic (NASDAQ:BDTX) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of $(0.47) by 27.66 percent. This is a 42.37 percent increase over losses of $(0.59) per share from the same period last year.